Ensera Design’s Maartje Pel discusses how medtech is embracing women-specific innovation to address historical gaps.

Vicarious Surgical is facing delisting from the New York Stock Exchange again. This is another setback the surgical robotics firm has faced in recent months. The NYSE sent the com ...

The healthcare industry faces an unprecedented cybersecurity crisis as connected medical devices proliferate at an alarming ...

Four major wearable tech companies are advancing blood pressure monitoring capabilities despite FDA warnings about medical ...

Discover Vivani Medical's GLP-1 implant offering steady, reversible drug delivery to enhance adherence and reduce unnecessary ...

Staar Surgical reported a $80.4M full-year loss and 23.7% revenue decline, with analysts maintaining hold ratings as the ...

Discover how Smith+Nephew's Landmark Knee System, featuring advanced kinematics, robotics, and more, could change the knee ...

Jack Heslin of Creatz3D explores how AI and 3D printing could create personalized invasive devices while highlighting ...

Trump Administration halts Medicare enrollment for DMEPOS suppliers for six months after CMS stopped $1.5B in suspected ...

Medtronic’s diabetes spinoff, MiniMed Group, has raised $560 million in an initial public offering. The offering is priced below its initial marketed range. Originally, Medtronic offered shares for ...

Mark McCarty has arguably the deepest reservoir of experience in med tech regulatory matters in all of the trade press. His ...

Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.